Skip to main content
Log in

Estimate of Volume/Flow Ratio of Gastrointestinal (GI) Fluids in Humans Using Pharmacokinetic Data

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Based on the mixing tank and tube models for drug absorption, the apparent absorption rate constant is shown to be related to the fraction of dose absorbed as a function of the volume/flow ratio of GI fluids. This analysis applies to drugs that are absorbed according to first-order kinetics, without limitation by dissolution rate, lumenal decomposition, or first-pass metabolism. Analysis of pharmacokinetic data of drugs that fit these criteria and are absorbed to varying extents enabled the estimation of the volume/flow ratio of GI fluids in humans; it was found to be 1.6 ± 0.3 (SE) hr using a mixing tank model and 0.32 ± 0.05 hr using a tube model. These findings are discussed with respect to volume and flow parameters used in the design of various types of drug absorption studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. H. Stricker. Drugs Made Ger. 13:35–42 (1970).

    Google Scholar 

  2. H. Stricker. Drugs Made Ger. 14:93–97 (1971).

    Google Scholar 

  3. J. B. Dressman, D. Fleisher, and G. L. Amidon. J. Pharm. Sci. 73:1274–1279 (1984).

    Google Scholar 

  4. J. B. Dressman, G. L. Amidon, and D. Fleisher. J. Pharm. Sci. 74:588–589 (1985).

    Google Scholar 

  5. J. B. Dressman and D. Fleisher. J. Pharm. Sci. 75:109–116 (1986).

    Google Scholar 

  6. B. C. Goodacre and R. J. Murray. J. Clin. Hosp. Pharm. 6:117–133 (1981).

    Google Scholar 

  7. N. F. H. Ho, H. P. Merkle, and W. I. Higuchi. Drug Dev. Ind. Pharm. 9:1111–1184 (1983).

    Google Scholar 

  8. P. Macheras and M. Symillides. Biopharm. Drug Dispos. 10:43–53 (1989).

    Google Scholar 

  9. D. Winne. J. Pharmacokin. Biopharm. 5:53–94 (1977).

    Google Scholar 

  10. R. L. Elliot, G. L. Amidon, and E. N. Lightfoot. J. Theor. Biol. 87:757–771 (1980).

    Google Scholar 

  11. G. L. Amidon, J. Kou, R. L. Elliot, and E. N. Lightfoot. J. Pharm. Sci. 69:1369–1373 (1980).

    Google Scholar 

  12. G. L. Amidon, P. J. Sinko, and D. Fleisher. Pharm. Res. 5:651–654 (1988).

    Google Scholar 

  13. P. J. Sinko, G. D. Leesman, and G. L. Amidon. Submitted for publication.

  14. R. L. Dillard, H. Eastman, and J. S. Fordtran. Gastroenterology 49:58–66 (1965).

    Google Scholar 

  15. W. G. Karr and W. O. Abbott. J.Clin. Invest. 14:893–900 (1935).

    Google Scholar 

  16. P. Kerlin, A. Zinsmeister, and S. Phillips. Gastroenterology 82:701–706 (1982).

    Google Scholar 

  17. E. A. Mayer, J. B. Thompson, D. Jehn, T. Reedy, J. Elashoff, and J. H. Meyer. Gastroenterology 83:184–192 (1982).

    Google Scholar 

  18. A. M. Stephen, A. C. Haddad, and S. F. Phillips. Gastroenterology 85:589–595 (1983).

    Google Scholar 

  19. R. E. Notari, J. L. DeYoung, and R. Reuning. J. Pharm. Sci. 61:135–138 (1972).

    Google Scholar 

  20. P. Miranda and R. M. Blum. J. Antimicrob. Chemother. 12(Suppl. B):29–37 (1983).

    Google Scholar 

  21. M. Gibaldi and D. Perrier. Pharmacokinetics, Marcel Dekker, New York, 1975, p. 37.

    Google Scholar 

  22. E. R. Garrett, J. R. Green, and M. Bialer. Biopharm. Drug Disp. 3:129–164 (1982).

    Google Scholar 

  23. V. Ascalone, M. Cisternino, N. Sicolo, and E. Palo. Arzneim. Forsch. 34:96–98 (1984).

    Google Scholar 

  24. A. A. Holazo, W. A. Colburn, J. H. Gustafson, R. L. Young, and M. Parsonnet. J. Pharm. Sci. 73:1108–1113 (1984).

    Google Scholar 

  25. K. J. Kripalani, D. N. McKinstry, S. M. Singhvi, D. A. Willard, R. A. Vukovich, and B. H. Migdalof. Clin. Pharmacol. Ther. 27:636–641 (1980).

    Google Scholar 

  26. J. Zhu and T. Koizumi. J. Pharmacobio-Dyn. 10:370–376 (1987).

    Google Scholar 

  27. L. Zecca, L. Reina, F. Scaglione, P. Ferrario, R. Pirola, G. Ceccarelli, M. Ciampini, and F. Fraschini. Arzneim. Forsch. 35:1870–1872 (1985).

    Google Scholar 

  28. J. Kampmann and L. Skovsted. Acta Pharmacol. Toxicol. 35:361–369 (1974).

    Google Scholar 

  29. S. L. Johnson, M. Mayersohn, and K. A. Conrad. Clin. Pharmacol. Ther. 38:331–335 (1985).

    Google Scholar 

  30. P. A. Koch, C. A. Schultz, R. J. Wills, S. L. Hallquist, and P. G. Welling. J. Pharm. Sci. 67:1533–1535 (1978).

    Google Scholar 

  31. T. M. Ludden, D. A. Boyle, D. Gieseker, G. T. Kennedy, M. H. Crawford, L. K. Ludden, and W. A. Clementi. J. Pharm. Sci. 77:779–783 (1988).

    Google Scholar 

  32. S. S. Walkenstein, J. K. Dubb, W. C. Randolph, W. J. Westlake, R. M. Stote, and A. P. Intoccia. Gastroenterology 74:360–365 (1978).

    Google Scholar 

  33. P. G. Welling, H. Huang, P. F. Hewitt, and L. Lyons. J. Pharm. Sci. 67:764–766 (1978).

    Google Scholar 

  34. P. K. Narang, R. Wilder, D. C. Chatterji, R. L. Yeager, and J. F. Garelli. Biopharm. Drug Disp. 4:233–248 (1983).

    Google Scholar 

  35. P. G. Welling, L. L. Lyons, W. A. Craig, and G. Trochta. Clin. Pharmacol. Ther. 17:475–480 (1975).

    Google Scholar 

  36. P. G. Welling, L. L. Lyons, F. L. S. Tse, and W. A. Craig. Clin. Pharmacol. Ther. 19:559–565 (1976).

    Google Scholar 

  37. P. G. Welling, H. Huang, P. A. Koch, W. A. Craig, and P. O. Masden. J. Pharm. Sci. 66:549–552 (1977).

    Google Scholar 

  38. P. G. Welling, H. Huang, P. F. Hewitt, and L. L. Lyons. J. Pharm. Sci. 67:764–766 (1978).

    Google Scholar 

  39. P. G. Welling and R. H. Barbhaiya. J. Pharm. Sci. 71:32–35 (1982).

    Google Scholar 

  40. P. G. Welling, P. A. Koch, C. C. Lau, and W. A. Craig. Antimicrob. Agents Chemother. 11:462–469 (1977).

    Google Scholar 

  41. F. L. S. Tse, J. M. Jaffe, K. A. Mart, and H. Z. Schwartz. J. Pharm. Pharmacol. 36:56–58 (1984).

    Google Scholar 

  42. J. R. Malagelada, J. S. Robertson, M. L. Brown, M. Remington, J. A. Duenes, G. M. Thomforde, and P. W. Carryer. Gastroenterology 87:1255–1263 (1984).

    Google Scholar 

  43. R. Oberle. In The Influence of the Inter-digestive Migrating Myoelectric Complex on the Gastric Emptying of Liquids and Oral Absorption of Cimetidine, Ph.D. thesis, University of Michigan, Ann Arbor, 1988.

  44. J.G. Moore, P. E. Christian, and R. E. Coleman. Digest. Dis. Sci. 26:16–22 (1981).

    Google Scholar 

  45. W. Brener, T. R. Hendrix, and P. R. McHugh. Gastroenterology 85:76–82 (1983).

    Google Scholar 

  46. S. S. Davis, R. Khosla, C. G. Wilson, and N. Washington. Int. J. Pharm. 35:253–258 (1987).

    Google Scholar 

  47. A.E. Merfeld, A. R. Mlodozeniec, M. A. Cortese, J. B. Rhodes, J. B. Dressman, and G. L. Amidon. J. Pharm. Pharmacol. 38:815–822 (1986).

    Google Scholar 

  48. N. Vidon, D. Evard, J. Godbillon, M. Rougier, M. Duval, J. P. Schoeller, J. J. Bernier, and J. Hirtz. Br. J. Clin. Pharmacol. 19:107S–112S (1985).

    Google Scholar 

  49. G. L. Amidon, A. E. Merfeld, and J. B. Dressman. J. Pharm. Pharmacol. 38:363–368 (1986).

    Google Scholar 

  50. P. J. Sinko and G. L. Amidon. Pharm. Res. 5:645–650 (1988).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Macheras, P., Reppas, C. & Dressman, J.B. Estimate of Volume/Flow Ratio of Gastrointestinal (GI) Fluids in Humans Using Pharmacokinetic Data. Pharm Res 7, 518–522 (1990). https://doi.org/10.1023/A:1015825018361

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015825018361

Navigation